We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Name | Symbol | Market | Type |
---|---|---|---|
Medigus Ltd | NASDAQ:MDGS | NASDAQ | Depository Receipt |
Price Change | % Change | Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 2.36 | 2.52 | 2.59 | 0 | 01:00:00 |
CUSIP No.
58471G102
|
Page 2 of 9 Pages
|
1
|
NAME OF REPORTING
PERSONS
OrbiMed Israel BioFund GP Limited Partnership
|
|||
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)
(a)
o
(b)
o
|
|
||
3
|
SEC USE ONLY
|
|||
4
|
SOURCE OF FUNDS (See Instructions)
N/A
|
|||
5
|
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)
|
o
|
||
6
|
CITIZENSHIP OR PLACE OF ORGANIZATION
State of Israel
|
|||
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
|
7
|
SOLE VOTING POWER
0
|
||
8
|
SHARED VOTING POWER
7,455,242 (1)
|
|||
9
|
SOLE DISPOSITIVE POWER
0
|
|||
10
|
SHARED DISPOSITIVE POWER
7,455,242 (1)
|
|||
11
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
7,455,242 (1)
|
|||
12
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions)
|
o
|
||
13
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
18.85% (2)
|
|||
14
|
TYPE OF REPORTING PERSON (See Instructions)
PN
|
(1)
|
Includes 3,000,000 Ordinary Shares evidenced by 600,000 American Depository Shares (“ADSs”) and 1,102,484 Ordinary Shares issuable upon the exercise of warrants.
|
(2)
|
Based on 38,447,034 Ordinary Shares outstanding as of September 12, 2016, as reported in the Issuer’s Prospectus Supplement filed with the Securities Exchange Commission (the “
SEC
”) on September 8, 2016.
|
CUSIP No.
58471G102
|
Page 3 of 9 Pages
|
1
|
NAME OF REPORTING
PERSONS
OrbiMed Israel GP Ltd.
|
|||
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)
(a)
o
(b)
o
|
|
||
3
|
SEC USE ONLY
|
|||
4
|
SOURCE OF FUNDS (See Instructions)
N/A
|
|||
5
|
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)
|
o
|
||
6
|
CITIZENSHIP OR PLACE OF ORGANIZATION
State of Israel
|
|||
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
|
7
|
SOLE VOTING POWER
0
|
||
8
|
SHARED VOTING POWER
7,455,242 (1)
|
|||
9
|
SOLE DISPOSITIVE POWER
0
|
|||
10
|
SHARED DISPOSITIVE POWER
7,455,242 (1)
|
|||
11
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
7,455,242 (1)
|
|||
12
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions)
|
o
|
||
13
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
18.85% (2)
|
|||
14
|
TYPE OF REPORTING PERSON (See Instructions)
CO
|
(1)
|
Includes 3,000,000 Ordinary Shares evidenced by 600,000 American Depository Shares (“ADSs”) and 1,102,484 Ordinary Shares issuable upon the exercise of warrants.
|
(2)
|
Based on 38,447,034 Ordinary Shares outstanding as of September 12, 2016, as reported in the Issuer’s Prospectus Supplement filed with the Securities Exchange Commission (the “
SEC
”) on September 8, 2016.
|
Item 1.
|
Security and Issuer.
|
Item 2.
|
Identity and Background.
|
Item 3.
|
Source and Amount of Funds or Other Consideration.
|
Item 4.
|
Purpose of Transaction.
|
Item 5.
|
Interest in Securities of the Issuer.
|
Item 6.
|
Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer.
|
Item 7.
|
Materials to be Filed as Exhibits.
|
Exhibit No.
|
Description
|
A
|
Joint Filing Agreement between OrbiMed Israel GP Ltd. and OrbiMed Israel BioFund GP Limited Partnership
|
ORBIMED ISRAEL BIOFUND GP LIMITED PARTNERSHIP | ||||
By: | OrbiMed Israel GP Ltd., its General Partner | |||
By: | /s/ Nissim Darvish | |||
Nissim Darvish | ||||
Director | ||||
ORBIMED ISRAEL GP LTD. | ||||
By: | /s/ Nissim Darvish | |||
Nissim Darvish | ||||
Director | ||||
Name
|
Position with Reporting
Person
|
Principal Occupation
|
Carl L. Gordon
American citizen
|
Director
|
Member
OrbiMed Advisors LLC
|
Nissim Darvish
|
Director
|
Senior Managing Director
OrbiMed Israel Partners Limited
|
Jonathan T. Silverstein
American citizen
|
Director
|
Member
OrbiMed Advisors LLC
|
1 Year Medigus Chart |
1 Month Medigus Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions